Clinical Trial Update: Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the safety and effects on blood donation in adults vaccinated with the rMenB+OMV NZ meningococcal B vaccine. The trial has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis Serogroup

Drugs mentioned

• rMenB+OMV NZ

Snippet

Sponsor: Novartis | Conditions: Meningitis, Meningococcal, Serogroup B | Phase 3 | Status: COMPLETED | Results posted: 2015-11-02